163 is the total number of securities Birchview Capital, LP has owned. The longest Birchview Capital, LP has owned a single stock is 36 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
AXDX | ACCELERATE DIAGNOSTICS... | 36 | 36 | 1.10% | 19.36% | 34.62% | Q4 2014 | Q3 2023 | 36 |
QDEL | QUIDELORTHO CORP | 36 | 36 | 0.47% | 2.67% | 8.60% | Q4 2014 | Q3 2023 | 36 |
MASI | MASIMO CORP | 36 | 36 | 0.36% | 1.04% | 2.21% | Q4 2014 | Q3 2023 | 36 |
PXD | PIONEER NATURAL RESOUR... | 36 | 36 | 0.22% | 0.38% | 0.74% | Q4 2014 | Q3 2023 | 36 |
XNCR | XENCOR INC | 35 | 35 | 0.10% | 0.24% | 0.42% | Q1 2015 | Q3 2023 | 35 |
NBIX | NEUROCRINE BIOSCIENCES... | 33 | 33 | 0.25% | 3.70% | 7.40% | Q3 2015 | Q3 2023 | 33 |
CORT | CORCEPT THERAPEUTICS INC | 32 | 32 | 0.23% | 0.61% | 1.16% | Q4 2015 | Q3 2023 | 32 |
BIIB | BIOGEN INC | 31 | 31 | 0.00% | 0.85% | 3.09% | Q4 2014 | Q2 2022 | 31 |
CFRX | CONTRAFECT CORP | 30 | 30 | 0.02% | 0.76% | 1.62% | Q2 2015 | Q3 2022 | 30 |
YTEN | YIELD10 BIOSCIENCE INC | 17 | 9 | 0.01% | 0.14% | 0.56% | Q1 2017 | Q3 2023 | 26 |
SIEN | SIENTRA INC | 18 | 7 | 0.01% | 0.30% | 0.84% | Q3 2015 | Q4 2022 | 25 |
FOLD | AMICUS THERAPEUTICS INC | 25 | 25 | 0.08% | 0.28% | 0.50% | Q3 2017 | Q3 2023 | 25 |
VNDA | VANDA PHARMACEUTICALS INC | 23 | 23 | 0.00% | 0.76% | 1.98% | Q4 2016 | Q2 2022 | 23 |
SLNO | SOLENO THERAPEUTICS INC | 23 | 23 | 0.23% | 0.67% | 1.39% | Q4 2017 | Q2 2023 | 23 |
GTHX | G1 THERAPEUTICS INC | 23 | 23 | 0.08% | 0.38% | 0.77% | Q1 2018 | Q3 2023 | 23 |
VRML | VERMILLION INC | 22 | 22 | 0.60% | 2.16% | 3.50% | Q4 2014 | Q1 2020 | 22 |
KPTI | KARYOPHARM THERAPEUTIC... | 22 | 22 | 0.26% | 1.02% | 2.52% | Q2 2018 | Q3 2023 | 22 |
OXFD | OXFORD IMMUNOTEC GLOBA... | 22 | 22 | 0.13% | 0.99% | 2.06% | Q3 2015 | Q4 2020 | 22 |
ECA | ENCANA CORP | 21 | 21 | 0.15% | 0.63% | 1.44% | Q4 2014 | Q4 2019 | 21 |
ARVN | ARVINAS INC | 21 | 21 | 0.24% | 0.49% | 0.90% | Q3 2018 | Q3 2023 | 21 |
CELG | CELGENE CORP (CELG) | 20 | 20 | 37.04% | 48.37% | 57.32% | Q4 2014 | Q3 2019 | 20 |
ALBO | ALBIREO PHARMA INC | 20 | 20 | 0.51% | 1.35% | 2.43% | Q1 2018 | Q4 2022 | 20 |
IMGN | IMMUNOGEN INC | 20 | 20 | 0.10% | 0.74% | 2.69% | Q4 2018 | Q3 2023 | 20 |
BMY | BRISTOL-MYERS SQUIBB CO | 19 | 19 | 0.60% | 29.22% | 40.76% | Q1 2019 | Q3 2023 | 19 |
EQT | EQT CORPORATION | 19 | 19 | 0.11% | 1.37% | 2.38% | Q4 2014 | Q2 2019 | 19 |
HROW | HARROW HEALTH INC | 19 | 19 | 0.56% | 1.15% | 2.98% | Q1 2019 | Q3 2023 | 19 |
CLR | CONTINENTAL RESOURCES INC | 10 | 4 | 0.15% | 0.74% | 1.84% | Q4 2014 | Q3 2022 | 19 |
CYTK | CYTOKINETICS INC | 10 | 9 | 0.05% | 0.37% | 0.85% | Q3 2017 | Q3 2023 | 19 |
IFRX | INFLARX NV | 15 | 4 | 0.07% | 0.21% | 0.55% | Q2 2018 | Q3 2023 | 19 |
ACAD | ACADIA PHARMACEUTICALS... | 18 | 18 | 0.16% | 2.67% | 4.48% | Q2 2019 | Q3 2023 | 18 |
XLRN | ACCELERON PHARMA INC | 18 | 18 | 0.24% | 0.85% | 1.50% | Q2 2017 | Q3 2021 | 18 |
OMED | ONCOMED PHARMACEUTICAL... | 18 | 18 | 0.05% | 0.34% | 0.76% | Q4 2014 | Q1 2019 | 18 |
BCRX | BIOCRYST PHARMACEUTICA... | 18 | 18 | 0.04% | 0.12% | 0.23% | Q2 2019 | Q3 2023 | 18 |
WKHS | WORKHORSE GROUP INC | 18 | 18 | 0.01% | 0.09% | 0.38% | Q2 2016 | Q3 2020 | 18 |
T107PS | WRIGHT MEDICAL GROUP NV | 17 | 17 | 0.36% | 0.48% | 0.77% | Q4 2015 | Q4 2019 | 17 |
APLS | APELLIS PHARMACEUTICAL... | 16 | 1 | 0.12% | 0.36% | 0.82% | Q2 2019 | Q3 2023 | 17 |
KALV | KALVISTA PHARMACEUTICA... | 17 | 17 | 0.19% | 0.34% | 0.61% | Q3 2019 | Q3 2023 | 17 |
DRNA | DICERNA PHARMACEUTICAL... | 17 | 17 | 0.03% | 0.25% | 0.46% | Q2 2017 | Q2 2021 | 17 |
UTHR | UNITED THERAPEUTICS CORP | 16 | 16 | 0.32% | 1.98% | 2.95% | Q4 2019 | Q3 2023 | 16 |
BIOL | BIOLASE INC | 16 | 16 | 0.05% | 0.82% | 1.81% | Q4 2014 | Q3 2018 | 16 |
ARNA | ARENA PHARMACEUTICALS INC | 16 | 16 | 0.26% | 0.81% | 1.32% | Q1 2018 | Q4 2021 | 16 |
AMRN | AMARIN CORP PLC | 16 | 16 | 0.00% | 0.73% | 1.11% | Q3 2018 | Q2 2022 | 16 |
NKTR | NEKTAR THERAPEUTICS | 11 | 5 | 0.01% | 0.40% | 1.09% | Q2 2018 | Q3 2023 | 16 |
ICPT | INTERCEPT PHARMACEUTIC... | 13 | 3 | 0.12% | 0.30% | 0.75% | Q1 2016 | Q3 2020 | 16 |
STOK | STOKE THERAPEUTICS INC | 15 | 15 | 0.10% | 0.31% | 0.71% | Q1 2020 | Q3 2023 | 15 |
CELGZ | CELGENE CORP (CELGZ) | 15 | 15 | 0.05% | 0.20% | 0.39% | Q4 2014 | Q2 2018 | 15 |
TGTX | TG THERAPEUTICS INC | 15 | 15 | 0.05% | 0.19% | 0.45% | Q2 2018 | Q4 2021 | 15 |
OVV | OVINTIV INC | 14 | 14 | 0.19% | 1.52% | 3.41% | Q2 2020 | Q3 2023 | 14 |
BLUE | BLUEBIRD BIO INC | 14 | 14 | 0.29% | 1.01% | 2.21% | Q2 2020 | Q3 2023 | 14 |
ETRN | EQUITRANS MIDSTREAM CO... | 14 | 14 | 0.60% | 0.75% | 1.06% | Q2 2020 | Q3 2023 | 14 |
VCYT | VERACYTE INC | 14 | 14 | 0.15% | 0.42% | 0.63% | Q3 2016 | Q4 2019 | 14 |
QTNT | QUOTIENT LTD | 14 | 14 | 0.12% | 0.28% | 0.54% | Q4 2014 | Q1 2018 | 14 |
BHVN | BIOHAVEN PHARMACEUTICA... | 13 | 13 | 0.07% | 0.73% | 1.59% | Q4 2019 | Q4 2022 | 13 |
VYGR | VOYAGER THERAPEUTICS INC | 13 | 13 | 0.21% | 0.34% | 0.50% | Q3 2017 | Q3 2020 | 13 |
BDSX | BIODESIX INC COM RST | 12 | 12 | 1.52% | 6.55% | 13.32% | Q4 2020 | Q3 2023 | 12 |
FHTX | FOGHORN THERAPEUTICS INC | 12 | 12 | 1.13% | 2.37% | 4.63% | Q4 2020 | Q3 2023 | 12 |
AWH | ASPIRA WOMENS HEALTH INC | 12 | 12 | 0.01% | 1.54% | 7.65% | Q2 2020 | Q1 2023 | 12 |
CCXI | CHEMOCENTRYX INC | 12 | 12 | 0.24% | 0.70% | 1.10% | Q4 2019 | Q3 2022 | 12 |
MRK | MERCK & CO INC | 12 | 12 | 0.33% | 0.48% | 0.63% | Q4 2014 | Q3 2017 | 12 |
TSRO | TESARO INC | 12 | 12 | 0.21% | 0.41% | 0.82% | Q4 2015 | Q3 2018 | 12 |
PGNY | PROGYNY INC | 9 | 3 | 0.23% | 0.37% | 0.57% | Q4 2019 | Q3 2023 | 12 |
SITOQ | SITO MOBILE LTD | 12 | 12 | 0.05% | 0.26% | 0.47% | Q2 2016 | Q1 2019 | 12 |
GNMX | AEVI GENOMIC MEDICINE INC | 12 | 12 | 0.01% | 0.08% | 0.17% | Q4 2016 | Q3 2019 | 12 |
PRTA | PROTHENA CORP PLC | 10 | 1 | 0.12% | 3.43% | 7.99% | Q3 2017 | Q3 2023 | 11 |
ALKS | ALKERMES PLC | 11 | 11 | 0.39% | 0.92% | 1.19% | Q1 2021 | Q3 2023 | 11 |
PTGX | PROTAGONIST THERAPEUTI... | 11 | 11 | 0.15% | 0.46% | 0.84% | Q1 2021 | Q3 2023 | 11 |
CGEM | CULLINAN ONCOLOGY INC | 11 | 11 | 0.19% | 0.46% | 1.49% | Q1 2021 | Q3 2023 | 11 |
NXTM | NXSTAGE MEDICAL INC | 11 | 11 | 0.11% | 0.31% | 0.46% | Q4 2014 | Q2 2017 | 11 |
MACK | MERRIMACK PHARMACEUTIC... | 11 | 11 | 0.03% | 0.18% | 0.28% | Q4 2014 | Q2 2017 | 11 |
ROKA | ROKA BIOSCIENCE INC | 11 | 11 | 0.06% | 0.14% | 0.26% | Q4 2014 | Q2 2017 | 11 |
GNCA | GENOCEA BIOSCIENCES INC | 11 | 11 | 0.03% | 0.11% | 0.22% | Q1 2016 | Q3 2018 | 11 |
AZYO | ELUTIA INC | 10 | 10 | 0.17% | 3.77% | 7.29% | Q2 2021 | Q3 2023 | 10 |
GOSS | GOSSAMER BIO INC | 9 | 1 | 0.09% | 0.50% | 1.34% | Q4 2019 | Q3 2023 | 10 |
NARI | INARI MEDICAL INC | 10 | 10 | 0.29% | 0.41% | 0.52% | Q2 2020 | Q3 2022 | 10 |
ARAY | ACCURAY INC | 10 | 10 | 0.11% | 0.39% | 0.63% | Q4 2014 | Q1 2017 | 10 |
ODT | ODONATE THERAPEUTICS INC | 10 | 10 | 0.18% | 0.35% | 0.51% | Q3 2018 | Q4 2020 | 10 |
COG | CABOT OIL & GAS CORP | 10 | 10 | 0.21% | 0.32% | 0.39% | Q4 2014 | Q1 2017 | 10 |
KNSA | KINIKSA PHARMACEUTICAL... | 10 | 10 | 0.17% | 0.27% | 0.44% | Q2 2021 | Q3 2023 | 10 |
MBLX | METABOLIX INC RESTRICTED | 9 | 9 | 0.18% | 2.15% | 4.04% | Q4 2014 | Q4 2016 | 9 |
ANGN | ANGION BIOMEDICA CORP | 9 | 9 | 0.02% | 0.28% | 1.16% | Q1 2021 | Q1 2023 | 9 |
ADXS | ADVAXIS INC | 9 | 9 | 0.12% | 0.21% | 0.38% | Q2 2015 | Q2 2017 | 9 |
INBX | INHIBRX INC | 8 | 8 | 0.58% | 1.02% | 1.37% | Q4 2021 | Q3 2023 | 8 |
DOCGO INC | 8 | 8 | 0.06% | 0.60% | 0.77% | Q4 2021 | Q3 2023 | 8 | |
VENTYX BIOSCIENCES INC | 8 | 8 | 0.24% | 0.57% | 1.11% | Q4 2021 | Q3 2023 | 8 | |
2SEVENTY BIO INC | 8 | 8 | 0.20% | 0.45% | 0.61% | Q4 2021 | Q3 2023 | 8 | |
MYGN | MYRIAD GENETICS INC | 8 | 8 | 0.20% | 0.37% | 0.59% | Q1 2018 | Q4 2019 | 8 |
SILK | SILK ROAD MEDICAL INC | 8 | 8 | 0.22% | 0.35% | 0.53% | Q4 2021 | Q3 2023 | 8 |
ISEE | IVERIC BIO INC | 8 | 8 | 0.10% | 0.32% | 0.74% | Q3 2021 | Q2 2023 | 8 |
TTHI | TRANSITION THERAPEUTIC... | 8 | 8 | 0.02% | 0.24% | 0.60% | Q4 2014 | Q3 2016 | 8 |
CERS | CERUS CORP | 8 | 8 | 0.07% | 0.17% | 0.30% | Q1 2015 | Q4 2016 | 8 |
CHRS | COHERUS BIOSCIENCES INC | 8 | 8 | 0.09% | 0.11% | 0.13% | Q1 2015 | Q4 2016 | 8 |
CNCE | CONCERT PHARMACEUTICAL... | 8 | 8 | 0.04% | 0.06% | 0.09% | Q1 2021 | Q4 2022 | 8 |
ARRY | ARRAY BIOPHARMA INC | 7 | 7 | 0.15% | 1.95% | 4.73% | Q4 2017 | Q2 2019 | 7 |
PHR | PHREESIA INC | 7 | 7 | 0.19% | 1.48% | 2.09% | Q1 2022 | Q3 2023 | 7 |
HNSN | HANSEN MEDICAL INC | 7 | 7 | 0.71% | 1.33% | 2.55% | Q4 2014 | Q2 2016 | 7 |
CMTA | CLEMENTIA PHARMACEUTIC... | 7 | 7 | 0.19% | 1.20% | 3.63% | Q3 2017 | Q1 2019 | 7 |
MDVN | MEDIVATION INC | 7 | 7 | 0.62% | 1.04% | 1.47% | Q4 2014 | Q2 2016 | 7 |
GILD | GILEAD SCIENCES INC | 5 | 2 | 0.22% | 0.85% | 1.33% | Q4 2014 | Q2 2020 | 7 |
LSF | LAIRD SUPERFOOD INC | 7 | 7 | 0.04% | 0.15% | 0.31% | Q1 2021 | Q3 2022 | 7 |
EQM | EQM MIDSTRM PRTNERS LP... | 6 | 6 | 0.54% | 1.45% | 2.21% | Q4 2018 | Q1 2020 | 6 |
ATRA | ATARA BIOTHERAPEUTICS INC | 6 | 6 | 0.24% | 0.72% | 1.12% | Q1 2018 | Q2 2019 | 6 |
AVEO | AVEO PHARMACEUTICALS INC | 6 | 6 | 0.17% | 0.62% | 1.06% | Q3 2021 | Q4 2022 | 6 |
AXGN | AXOGEN INC | 4 | 2 | 0.24% | 0.45% | 0.74% | Q4 2017 | Q3 2023 | 6 |
TBIO | TRANSLATE BIO INC | 6 | 6 | 0.26% | 0.33% | 0.49% | Q1 2020 | Q2 2021 | 6 |
XENE | XENON PHARMACEUTICALS INC | 6 | 6 | 0.22% | 0.27% | 0.29% | Q2 2022 | Q3 2023 | 6 |
CLVS | CLOVIS ONCOLOGY INC | 6 | 6 | 0.15% | 0.24% | 0.35% | Q1 2017 | Q2 2018 | 6 |
RPTP | RAPTOR PHARMACEUTICAL ... | 6 | 6 | 0.12% | 0.20% | 0.38% | Q1 2015 | Q2 2016 | 6 |
PACB | PACIFIC BIOSCIENCES OF... | 6 | 6 | 0.05% | 0.11% | 0.16% | Q1 2016 | Q2 2017 | 6 |
BMYRT | BMY CVR RTS 03/31/21 | 5 | 5 | 0.44% | 1.54% | 2.38% | Q4 2019 | Q4 2020 | 5 |
ATEC | ALPHATEC HOLDINGS INC | 5 | 5 | 0.06% | 0.76% | 1.08% | Q3 2022 | Q3 2023 | 5 |
DOVA | DOVA PHARMACEUTICALS INC | 5 | 5 | 0.28% | 0.47% | 0.93% | Q3 2018 | Q3 2019 | 5 |
PTCT | PTC THERAPEUTICS INC | 5 | 5 | 0.28% | 0.43% | 0.60% | Q4 2014 | Q4 2015 | 5 |
IRTC | IRHYTHM TECHNOLOGIES INC | 5 | 5 | 0.16% | 0.32% | 0.45% | Q3 2021 | Q3 2022 | 5 |
TPTX | TURNING POINT THERAPEU... | 5 | 5 | 0.16% | 0.31% | 0.44% | Q2 2021 | Q2 2022 | 5 |
ZNTL | ZENTALIS PHARMACEUTICA... | 5 | 5 | 0.16% | 0.30% | 0.43% | Q2 2021 | Q2 2022 | 5 |
SRPT | SAREPTA THERAPEUTICS INC | 5 | 5 | 0.19% | 0.23% | 0.27% | Q3 2022 | Q3 2023 | 5 |
LXRX | LEXICON PHARMACEUTICAL... | 5 | 5 | 0.13% | 0.22% | 0.31% | Q4 2018 | Q4 2019 | 5 |
AGIO | AGIOS PHARMACEUTICALS INC | 5 | 5 | 0.13% | 0.17% | 0.22% | Q4 2014 | Q4 2015 | 5 |
PRTK | PARATEK PHARMACEUTICAL... | 5 | 5 | 0.08% | 0.16% | 0.38% | Q2 2016 | Q2 2017 | 5 |
OPK | OPKO HEALTH INC | 4 | 1 | 0.08% | 0.14% | 0.23% | Q3 2016 | Q3 2018 | 5 |
AKBA | AKEBIA THERAPEUTICS INC | 5 | 5 | 0.00% | 0.12% | 0.23% | Q2 2021 | Q2 2022 | 5 |
IRONWOOD PHARMACEUTICA... | 5 | 5 | 0.08% | 0.10% | 0.13% | Q2 2017 | Q2 2018 | 5 | |
LTHM | LIVENT CORP | 5 | 5 | 0.04% | 0.07% | 0.13% | Q4 2018 | Q4 2019 | 5 |
SWN | SOUTHWESTERN ENERGY CO | 4 | 4 | 0.79% | 1.16% | 1.53% | Q4 2014 | Q3 2015 | 4 |
COLL | COLLEGIUM PHARMACEUTIC... | 4 | 4 | 0.74% | 0.88% | 0.99% | Q2 2015 | Q1 2016 | 4 |
AAAP | ADVANCED ACCELERATOR A... | 4 | 4 | 0.16% | 0.60% | 1.05% | Q1 2017 | Q4 2017 | 4 |
PROG | PROGENITY INC | 4 | 4 | 0.28% | 0.60% | 0.76% | Q4 2020 | Q3 2021 | 4 |
DERM | DERMIRA INC | 4 | 4 | 0.17% | 0.57% | 0.88% | Q1 2019 | Q4 2019 | 4 |
TXG | 10X GENOMICS INC | 4 | 4 | 0.26% | 0.48% | 0.74% | Q4 2022 | Q3 2023 | 4 |
TRNX | TORNIER NV | 4 | 4 | 0.39% | 0.48% | 0.73% | Q4 2014 | Q3 2015 | 4 |
HALO | HALOZYME THERAPEUTICS INC | 4 | 4 | 0.27% | 0.32% | 0.40% | Q4 2022 | Q3 2023 | 4 |
KURA | KURA ONCOLOGY INC | 4 | 4 | 0.12% | 0.27% | 0.51% | Q4 2015 | Q3 2016 | 4 |
KROS | KEROS THERAPEUTICS INC | 4 | 4 | 0.19% | 0.22% | 0.24% | Q4 2022 | Q3 2023 | 4 |
ALDR | ALDER BIOPHARMACEUTICA... | 4 | 4 | 0.09% | 0.19% | 0.29% | Q2 2016 | Q1 2017 | 4 |
PBYI | PUMA BIOTECHNOLOGY INC | 4 | 4 | 0.10% | 0.18% | 0.27% | Q4 2014 | Q3 2015 | 4 |
PQ | PETROQUEST ENERGY INC | 4 | 4 | 0.09% | 0.16% | 0.26% | Q4 2014 | Q3 2015 | 4 |
TXMD | THERAPEUTICSMD INC | 4 | 4 | 0.01% | 0.05% | 0.08% | Q1 2021 | Q4 2021 | 4 |
EPZM | EPIZYME INC | 3 | 3 | 0.56% | 0.69% | 0.83% | Q1 2020 | Q3 2020 | 3 |
TVTX | TRAVERE THERAPEUTICS INC | 3 | 3 | 0.46% | 0.54% | 0.62% | Q1 2023 | Q3 2023 | 3 |
IMMY | IMPRIMIS PHARMACEUTICA... | 3 | 3 | 0.27% | 0.52% | 0.97% | Q2 2018 | Q4 2018 | 3 |
AEGR | AEGERION PHARMACEUTICA... | 3 | 3 | 0.40% | 0.50% | 0.63% | Q1 2015 | Q3 2015 | 3 |
AVEO | AVEO PHARMACEUTICALS INC | 3 | 3 | 0.15% | 0.20% | 0.26% | Q1 2018 | Q3 2018 | 3 |
ARQT | ARCUTIS BIOTHERAPEUTIC... | 3 | 3 | 0.15% | 0.15% | 0.15% | Q1 2021 | Q3 2021 | 3 |
SLDB | SOLID BIOSCIENCES INC | 3 | 3 | 0.10% | 0.14% | 0.18% | Q1 2018 | Q3 2018 | 3 |
XBIT | XBIOTECH INC | 3 | 3 | 0.05% | 0.11% | 0.21% | Q1 2019 | Q3 2019 | 3 |
NSPR | INSPIREMD INC | 3 | 3 | 0.08% | 0.10% | 0.11% | Q4 2014 | Q2 2015 | 3 |
MYOK | MYOKARDIA INC | 2 | 2 | 0.58% | 0.75% | 0.91% | Q2 2020 | Q3 2020 | 2 |
ASPX | AUSPEX PHARMACEUTICALS... | 2 | 2 | 0.47% | 0.63% | 0.78% | Q4 2014 | Q1 2015 | 2 |
KDNY | CHINOOK THERAPEUTICS INC | 2 | 2 | 0.27% | 0.35% | 0.43% | Q1 2023 | Q2 2023 | 2 |
ECYT | ENDOCYTE INC | 2 | 2 | 0.09% | 0.13% | 0.16% | Q2 2018 | Q3 2018 | 2 |
MREO | MEREO BIOPHARMA GROUP PLC | 2 | 2 | 0.07% | 0.11% | 0.15% | Q2 2019 | Q3 2019 | 2 |
QGEN | QIAGEN NV | 1 | 1 | 0.49% | 0.49% | 0.49% | Q4 2019 | Q4 2019 | 1 |
SHPG | SHIRE PLC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2018 | Q1 2018 | 1 |
RLYP | RELYPSA INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q2 2016 | Q2 2016 | 1 |
ABLX | ABLYNX NV | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2018 | Q1 2018 | 1 |
APTX | APTINYX INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2018 | Q2 2018 | 1 |
PFE | PFIZER INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2021 | Q4 2021 | 1 |
AMAG | AMAG PHARMACEUTICALS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2018 | Q4 2018 | 1 |
MDGN | MEDGENICS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2016 | Q3 2016 | 1 |
HOOK | HOOKIPA PHARMA INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2021 | Q2 2021 | 1 |
MCRB | SERES THERAPEUTICS INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2016 | Q2 2016 | 1 |
CALA | CALITHERA BIOSCIENCES INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2015 | Q2 2015 | 1 |
ANTH | ANTHERA PHARMACEUTICAL... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2017 | Q4 2017 | 1 |
Download |
The securities at the top of the list , including ACCELERATE DIAGNOSTICS INC, QUIDELORTHO CORP, and MASIMO CORP, are the highest-conviction holdings of Birchview Capital, LP.
The conviction is calculated by counting the number of quarters a security has been reported by Birchview Capital, LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Birchview Capital, LP owns currently or has owned in the past.